目前,阿糖胞苷(Ara-C)是治疗急性非淋巴细胞白血病的主要药物之一。Ara-C单独应用常规剂量每天100～200mg/m~2,可取得25～42％的完全缓解率;如和其他药物联合应用,特别是与蒽环类抗生素联合,完全缓解率可提高达60～80％。但急性白血病复发的治疗仍为一个较困难的问 Currently, cytarabine (Ara-C) is one of the main drugs for the treatment of acute non-lymphocytic leukemia. Ara-C alone with conventional doses of 100 ~ 200mg / m ~ 2 per day, can obtain complete remission rate of 25 to 42%; such as combined with other drugs, especially with anthracycline, the complete remission rate can be increased up to 60 ~ 80%. However, the treatment of acute leukemia recurrence is still a more difficult question